-gepant
A CGRP receptor antagonist: blocks a nerve signal involved in migraine.
- Drugs ending in -gepant: 6
- Approved somewhere: 4
- With a US drug page: 4
- Stem
- -gepant
- Class
- Migraine drugs that block the CGRP receptor
- Most common targets
- CALCRL (6), CALCRL, RAMP1 (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -gepant, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Atogepant | Approved | CALCRL | Calcitonin gene-related peptide type 1 receptor antagonist |
| Rimegepant | Approved | CALCRL | Calcitonin gene-related peptide type 1 receptor antagonist |
| Ubrogepant | Approved | CALCRL | Calcitonin gene-related peptide type 1 receptor antagonist |
| Zavegepant | Approved | CALCRL, RAMP1, CALCRL | Calcitonin-gene-related peptide receptor, CALCRL/RAMP1 antagonist |
| Telcagepant | Phase 3 | CALCRL | Calcitonin gene-related peptide type 1 receptor antagonist |
| Olcegepant | Phase 2 | CALCRL | Calcitonin gene-related peptide type 1 receptor antagonist |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO